Literature DB >> 20922398

Neuropathology in Parkinson's disease with mild cognitive impairment.

Kurt A Jellinger.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20922398     DOI： 10.1007/s00401-010-0755-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  17 in total

1.  Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease.

Authors:  Kurt Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2011-09-30       Impact factor: 3.575

Review 2.  Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Authors:  Jennifer G Goldman; Neelum T Aggarwal; Cynthia D Schroeder
Journal:  Neurodegener Dis Manag       Date:  2015-10-30

3.  The pattern of cortical atrophy in Parkinson's disease with mild cognitive impairment according to the timing of cognitive dysfunction.

Authors:  Ji E Lee; Kyoo H Cho; Myonghwan Kim; Young H Sohn; Phil Hyu Lee
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

Review 4.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

Review 5.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

6.  Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.

Authors:  Laura Brennan; Kathryn M Devlin; Sharon X Xie; Dawn Mechanic-Hamilton; Baochan Tran; Howard H Hurtig; Alice Chen-Plotkin; Lama M Chahine; James F Morley; John E Duda; David R Roalf; Nabila Dahodwala; Jacqueline Rick; John Q Trojanowski; Paul J Moberg; Daniel Weintraub
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

Review 7.  Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2012-02-18       Impact factor: 3.575

Review 8.  Morphological basis of Parkinson disease-associated cognitive impairment: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-20       Impact factor: 3.850

Review 9.  Neuropathological basis of nonmotor manifestations of Parkinson's disease.

Authors:  Charles H Adler; Thomas G Beach
Journal:  Mov Disord       Date:  2016-03-31       Impact factor: 10.338

10.  Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function.

Authors:  Penny A Macdonald; Oury Monchi
Journal:  Parkinsons Dis       Date:  2011-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.